As shown in Figure S4, there was a significant change in the expression of PTGS1 in diverse tumors such as the brain, kidney, nasopharyngeal, colon, leukemia, and other hematopoietic reticuloendothelial systems and various related pathophysiological conditions. Here, PTGS1 is linked to leukemia.